BioInfra Co

BioInfra Co Rule of 40

The Rule of 40 of BioInfra Co (199730.KQ) as of Oct 19, 2026 is -37.48 %. In the previous year, Rule of 40 was -42.36 % — a change of -11.52% (higher).

Rule of 40

-37.48 %

YoY

-11.52%

Last updated:

Rule of 40 of BioInfra Co is 2025 -37.48 % . Rule of 40 of BioInfra Co was 2024 -42.36 % . It decreases by -11.52% higher compared to the previous year.

The BioInfra Co Rule of 40 history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Rule of 40
Date
Rule of 40
Jan 1, 2021
80.24 KRW
Jan 1, 2022
36.57 KRW
Jan 1, 2023
-10.62 KRW
Jan 1, 2024
-42.36 KRW
Jan 1, 2025
-37.48 KRW
The BioInfra Co Rule of 40 history
YEARRule of 40YoY
-37.48 %-11.52%
-42.36 %+298.75%
-10.62 %-129.05%
36.57 %-54.43%
80.24 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

BioInfra Co Stock analysis

What does BioInfra Co do? BioInfra Co Ltd, based in Yongin, South Korea, operates in the Health Care sector, specifically within Life Sciences Tools & Services. The company focuses on research and development of medicines, chemical substances, and medical devices, alongside conducting drug development, non-clinical and clinical trials, and producing health functional foods. Listed on March 2, 2023, BioInfra employs 113 full-time staff. BioInfra Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about BioInfra Co stock

Rule of 40 of BioInfra Co is -37.48 % in 2025.

On Eulerpool you can find the complete historical development of Rule of 40 BioInfra Co since 2006 – with annual values, charts, and detailed analysis.

The Rule of 40 states that a company's revenue growth rate plus profit margin should exceed 40%. It is widely used to evaluate SaaS and high-growth companies.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Quality — BioInfra Co

AAQSPiotroski F-ScoreAltman Z-ScoreGraham NumberRule of 40

All Key Metrics — BioInfra Co